Bacillus anthracis: Difference between revisions
From IDWiki
Bacillus anthracis
(→) |
m (Text replacement - "[[Cellular shape::" to "[[Shape::") |
||
| Line 5: | Line 5: | ||
===Microbiology=== |
===Microbiology=== |
||
*[[Stain::Gram-positive]] [[ |
*[[Stain::Gram-positive]] [[Shape::bacillus]] that is distinguished from other [[Bacillus species]] by being [[Motility::non-motile]] and [[Hemolysis::non-hemolytic]] |
||
*Colonies are gray, flat, and may have a "Medusa head" or "comet" appearance |
*Colonies are gray, flat, and may have a "Medusa head" or "comet" appearance |
||
Revision as of 14:25, 8 October 2020
- Causes anthrax
Background
Microbiology
- Gram-positive bacillus that is distinguished from other Bacillus species by being non-motile and non-hemolytic
- Colonies are gray, flat, and may have a "Medusa head" or "comet" appearance
Clinical Manifestations
Cutaneous anthrax
- Caused by inoculation of spores into soft tissue
- Incubation period of 2 to 5 days
- Lesion develops at site of inoculation, starting as erythemaous papule, then ulceration, then eschar
- May progress to sepsis
Pulmonary anthrax
- Caused by inhalation of spores
- Also known as woolsorter's disease
- Start with malaise, fever, and nonproductive cough, followed by respiratory distress, severe pulmonary edema, and death
Gastrointestinal anthrax
- Caused by ingestion of spores
- Infects oropharynx or abdomen
- Causes sepsis
References
- ^ Tucker Maxson, Thiphasone Kongphet-Tran, Thitipong Mongkolrattanothai, Tatiana Travis, Katherine Hendricks, Corinne Parker, Heather P McLaughlin, Julia Bugrysheva, Frank Ambrosio, Pierre Michel, Blake Cherney, Christine Lascols, David Sue. Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947–2019. Clinical Infectious Diseases. 2022;75(Supplement_3):S373-S378. doi:10.1093/cid/ciac520.
